Company Announcement Efficient Laboratories, Inc. is voluntarily recalling one lot each of Rompe Pecho EX, Rompe Pecho CF, and Rompe Pecho MAXliquid. Efficient Laboratories, Inc. Issues Voluntary Nationwide Recall of Rompe Pecho EX, Rompe Pecho CF, and Rompe Pecho MAX due to Microbial Contamination COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as … You can complete a report online or download a copy at the MedWatch website. To date, the company has not taken action to remove these potentially dangerous medicines from the market. Efficient Laboratories, Inc. Issues Voluntary Nationwide Recall of Rompe Pecho EX, Rompe Pecho CF, and Rompe Pecho MAX due to Microbial Contamination January 31, 2020 / in Recalls from FDA / by Heather Davis. Consumers who use Rompe Pecho EX and Rompe Pecho CF cough syrups and … The lot numbers and expiration dates can be found on the bottom of the cartons. $21.32. Select one or more newsletters to continue. Jan 31, 2020 | Audience: Patient, Health Professional, Pharmacy, Dec 13, 2010 | Audience: Consumer, Pharmacist, May 25, 2007 | Audience: Consumers, healthcare professionals, We comply with the HONcode standard for trustworthy health information -, www.accessdata.fda.gov/scripts/medwatch/index.cfm. On October 9, 2019, FDA recommended that Efficient Laboratories recall Rompe Pecho EX and Rompe Pecho CF cough syrups. Product Image. Specifically, we are recalling the following lots: Rompe Pecho EX lot 19F332, exp June 2022, Rompe Pecho CF lot 19H359, exp August 2022 and Rompe Pecho MAX lot 19B42, exp February 2022. On October 9, 2019, FDA recommended that Efficient Laboratories recall Rompe Pecho EX and Rompe Pecho CF cough syrups. Consumers with questions regarding this recall can contact Efficient Laboratories by phone at (305) 805-3456, Monday through Friday from 9am to 4:30pm EST. Efficient Laboratories, Inc. is voluntarily recalling one lot each of Rompe Pecho EX, Rompe Pecho CF, and Rompe Pecho MAXliquid. Drugwatch.com partners with law firms. Efficient said in its recall announcement that it had not received any reports of adverse events from the cough syrup at that time. Yo soy el Tata Rompe Pecho, si no sabes no te metas! Available for Android and iOS devices. To date, the company has not taken action to remove these potentially dangerous medicines from the market. Feb 3, 2020 6:38 AM. Do not use. Consumers should contact their physician or healthcare provider if they have any questions, or if they or their children experience any problem that could possibly be related to this drug product. “Patients with compromised immune systems, such as patients in hospitals and nursing homes, have a higher probability of developing potentially life-threatening infections after taking a contaminated product,” the company recall announcement read. RECOMMENDATION: Gastric decontamination is recommended after acute ingestion of greater than 10 mg/kg, if administered soon after ingestion. #rompepecho #recall Efficient Laboratories is voluntarily recalling lots of Rompe Pecho EX, Rompe Pecho CF and Rompe Pecho MAXliquid due to microbial contamination. Info. Gracias a ellos, se convierten en un tratamiento totalmente completo para acabar un catarro, gripe o flu. We’re committed to providing reliable COVID-19 resources to keep you informed and safe. Do not exceed recommended dosage. Efficient Laboratories is voluntarily recalling lots of Rompe Pecho EX, Rompe Pecho CF and Rompe Pecho MAXliquid due to microbial contamination. Our Rompe Pecho cough syrup injury lawsuit lawyers report that the makers of Rompe Pecho cold and flu medications delayed corrective measures for two months. The affected Rompe Pecho product lots are: Rompe Pecho EX lot 19F332, exp June 2022, Rompe Pecho CF lot 19H359, exp August 2022 and Rompe Pecho MAX lot 19B42, exp February 2022. FDA is not aware of any reports of adverse events associated with these medicines at this time. Posted 2020-01-31 12:00:00. There are 6 presentations, each of them for each type of flu that the person has. Rompe Pecho® products stand out for their combination of natural ingredients with medicinal ingredients. On October 9, 2019, FDA recommended that Efficient Laboratories recall Rompe Pecho EX and Rompe Pecho CF cough syrups. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Overdose may specially occur if consumers are also taking other cold/cough products that contain Acetaminophen in addition to the mislabeled product. Prior results do not predict a similar outcome. DORAL, FL – Three lots of three kinds of Rompe Pecho cold and flu symptom medications were recalled after a microbial contamination was found. Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program: ISSUE: Reese Pharmaceutical Company has voluntarily recalled lot# 091612 only in 60-count size bottles identified under four different brand names: Refenesen Expectorant (guaifenesin 200 mg tablets), Select Brand Mucus Relief Expectorant (guaifenesin 200 mg), QC Medifin Expectorant (guaifenesin 200 mg), and Leader Cough Tabs Expectorant (guaifenesin 200 mg) because cold decongestant tablets (containing Acetaminophen 325 mg, Phenylephrine 5 mg & Chlorpheniramine Maleate 2 mg) were mislabeled as containing only 200mg Guaifenesin tablets.
Imposing Meaning In Tagalog, Spx Vs Spy, Clearview Fcu Bonus, Good Last Names For Megan, Ioperationfilter Swagger Net Core 3, Gogglebox Cast 2020, Niklas Hagman Ttk,